U-4042

TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMOR (PECOMA) WITH A DOSE OF 45 MG/M2 ADMINISTERED ON DAYS 1 AND 8 OF A 21-DAY CYCLE